Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

Publications

Date Source Title
Blood
22nd EHA Congress
22nd EHA Congress
2017 ASCO Annual Meeting
Blood
Blood
2017 ASCO Annual Meeting
2017 ASCO Annual Meeting
2017 ASCO Annual Meeting
2017 ASCO Annual Meeting
Annual Review of Biochemistry
Keystone on Tumor Metabolism
Cancer Discovery
58th ASH Annual Meeting
58th ASH Annual Meeting
58th ASH Annual Meeting
58th ASH Annual Meeting
58th ASH Annual Meeting
58th ASH Annual Meeting
58th ASH Annual Meeting
2016 SNO Annual Meeting
2016 CTOS Annual Meeting
Cell Reports
Journal of Inherited Metabolic Disease
21st EHA Congress
21st EHA Congress
21st EHA Congress
21st EHA Congress
21st EHA Congress
Cell Reports
Annals of Oncology
Immunity Journal
PNAS Journal
Blood Journal
PLOS One
Chemistry & Biology
Nature
The Journal of Biological Chemistry
Science Magazine
Science Magazine
Chemistry & Biology
Genes & Development
Nature
Science Magazine
Cancer Cell
Nature
The Oncologist
Biochemistry
Nature
Cancer Cell
Trends in Molecular Medicine
Cancer Cell
Journal of Experimental Medicine
Nature